It promotes tumor growth and survival primarily through suppression of PTEN, resulting in PI3K/AKT pathway activation [24], and by targeting PDCD4, which enhances AP-1-mediated transcription of genes driving proliferation and invasion [25]. The gene discussed is AKT1; the disease is neoplasm.